12-122183253-A-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001098519.2(LRRC43):āc.109A>Cā(p.Lys37Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000222 in 1,566,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_001098519.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRC43 | NM_001098519.2 | c.109A>C | p.Lys37Gln | missense_variant | 1/12 | ENST00000339777.5 | NP_001091989.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRC43 | ENST00000339777.5 | c.109A>C | p.Lys37Gln | missense_variant | 1/12 | 5 | NM_001098519.2 | ENSP00000344233.4 | ||
LRRC43 | ENST00000537729.5 | c.-405-1266A>C | intron_variant | 5 | ENSP00000438751.1 | |||||
LRRC43 | ENST00000541498.5 | n.128A>C | non_coding_transcript_exon_variant | 1/4 | 5 | |||||
LRRC43 | ENST00000537113.5 | n.71+181A>C | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000232 AC: 43AN: 185232Hom.: 0 AF XY: 0.000200 AC XY: 21AN XY: 104918
GnomAD4 exome AF: 0.000235 AC: 332AN: 1414678Hom.: 0 Cov.: 32 AF XY: 0.000205 AC XY: 144AN XY: 703258
GnomAD4 genome AF: 0.000105 AC: 16AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74336
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 31, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at